This study is the first to reveal that Curcumol suppresses the progression of colorectal cancer (CRC) by activating the VHL/HIF-1α signaling pathway, thereby significantly inhibiting hypoxia-driven glycolysis. The gene discussed is HIF1A; the disease is colorectal carcinoma.